Related Experiment Videos
[Ferakril--a local-action hemostatic].
Farmakologiia I Toksikologiia
|September 1, 1991
Summary
Feracryl, a novel local hemostatic agent, demonstrated significant efficacy in preclinical and clinical studies. Its safety profile, including toxicity and anesthetic effects, was thoroughly evaluated alongside its antimicrobial properties.
Area of Science:
- Biomedical Engineering
- Pharmacology
- Surgical Innovation
Background:
- Local hemostatic agents are crucial in managing surgical bleeding.
- Feracryl is a new agent with potential applications in various medical procedures.
- Comprehensive evaluation is needed to establish its efficacy and safety.
Purpose of the Study:
- To present preclinical and clinical data for feracryl.
- To assess feracryl's hemostatic, toxicological, anesthetic, and antimicrobial properties.
- To report the outcomes of clinical trials involving feracryl.
Main Methods:
- Preclinical studies investigating hemostatic activity and toxicity (acute, subacute, chronic).
- In vitro and in vivo assessments of anesthetic, antibacterial, and antifungal effects.
- Clinical trials to evaluate feracryl's performance in human subjects.
Main Results:
- Feracryl exhibited significant local hemostatic activity.
- The agent demonstrated an acceptable safety profile across toxicity studies.
- Antibacterial and antifungal properties were observed, alongside a notable anesthetic effect.
Conclusions:
- Feracryl is an effective local hemostatic agent with a favorable safety profile.
- The drug possesses valuable antimicrobial and anesthetic characteristics.
- Clinical trial results support the use of feracryl in surgical settings.